In this preliminary report we have investigated the ability of FDG-PET to differBackground -Positron emission tomography (PET) with 18-fluorodeoxyglucose entiate between malignant and non-malignant pleural disease. (FDG) is an accurate method for differentiating benign from malignant disease. The use of FDG-PET for the aetiological diagnosis of pleural disease was in-Methods vestigated in 25 patients.
The diagnostic efficacy of PET-FDG imaging as a means of differentiating malignant from benign pleural lesions was evaluated by calPleural effusion or pleural thickening are the culating the sensitivity, specificity, positive premost common radiographic manifestations of dictive value, and negative predictive value. For pleural disease but aetiological diagnosis is each parameter the 95% confidence intervals difficult. Most patients who are admitted to a (95% CI) were given. hospital with pleural disease undergo extensive diagnostic procedures including chest radiography, thoracocentesis with various chemical, has a low sensitivity. 1 (diagnosed by plain radiographic follow up after thoracocentesis), one pleural fibroma (thoraPositron emission tomography (PET) with within the pleural thickening. The sensitivity of the method was 100% (95% CI 79.4 to 100) with a negative predictive value of 100% (95% CI 59 to 100). The 18 FDG uptake was intense in 14 cases and moderate in two. Figure 1 shows CT and FDG-PET scans in a patient with diffuse unilateral involvement of the pleura by a sarcomatous type mesothelioma.
PET imaging showed the absence of 18 FDG uptake within the pleura and correctly identified seven benign lesions. In two patients with benign pleural disease there was an increase in FDG uptake which was moderate and localised to the lateral pleural space; one patient had a parapneumonic effusion and the second a tuberculous pleuritis. Figure 2 shows CT and FDG-PET scans in a patient with benign pleural disease. The specificity of the FDG-PET imaging was 78% (95% CI 40 to 97) and the positive predictive value was 89% (95% CI 65.3 to 98.6).
Discussion
It is easy to confirm the presence of a pleural 
abnormality by clinical examination and CT
The CT scan shows a circumferential and nodular pleural scanning of the thorax. However, the mor- but our preliminary results suggest that it may be useful in the evaluation of certain pleural diseases. Benign and malignant primary pleural tumours are rare and a "limited" thoracotomy is often required to establish the diagnosis. In our study the malignant or benign nature of these primary pleural abnormalities (n = 6) was correctly identified by this non-invasive technique. Metastatic pleural lesions are common but may be difficult to diagnose so that thoracoscopy, requiring admission to hospital for five days, is necessary. In our series there were 13 cases of metastatic pleural involvement. All showed a diffuse increase in 18 FDG uptake which was intense in 11 cases and moderate in two. PET imaging with visual interpretation appears to be less conclusive in infectious pleural diseases; in our series we observed two such cases with moderate FDG uptake.
On the basis of these preliminary results we believe that the PET technique could reduce the number of open pleural biopsies and "limited" thoracotomies performed for benign pleural disease. In particular, if a patient has localised pleural thickening which does not exhibit 18 FDG uptake, we think it is unnecessary to subject the patient to an invasive procedure as a first step. This will have to be confirmed in a larger study.
Figure 2 (A) CT scan and (B) FDG-PET imaging in
We do not routinely quantify our PET data 
